Alembic Pharmaceuticals share price rose in the opening trade on June 8 after the company signed a shareholders' agreement to invest in a newly incorporated Canadian entity, Canada Inc., aimed at ...

AI Quick Read Alembic Pharmaceuticals Ltd is expanding its branded speciality drugs portfolio in the US as part of a ‘twin engine play’ to boost growth in the market as generic pricing pressure ...

Vadodara: Alembic Pharmaceuticals is adding another regulated-market approval to its portfolio, reinforcing its presence in the US generics space with a key oncology and autoimmune therapy product.

Vadodara: Alembic Pharmaceuticals has strengthened its US generics portfolio with a key regulatory approval, positioning itself to tap into a high-value diabetes treatment market. Alembic ...

Alembic Pharmaceuticals Limited (Alembic) announced the first prescription-based sale of Pivya (pivmecillinam) tablets, an oral prescription antibiotic, following its recent commercial launch in the ...

BEDMINSTER, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Alembic Therapeutics is pleased to announce the U.S. availability of Pivya® (pivmecillinam) tablets, 185mg, an oral prescription antibiotic. Pivya ...

Alembic Pharmaceuticals Ltd on Monday said it has received tentative approval from the US health regulator for its Bosutinib tablets used in the treatment of certain types of cancer. The tentative ...

Drugmaker Alembic Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Travoprost Ophthalmic Solution ...

Alembic Pharmaceuticals Share Price | The tablets are indicated for the management of chronic stable angina and angina due to coronary artery spasm. Alembic Pharmaceuticals share price rose 2 percent ...

Alembic Pharmaceuticals Limited (Alembic), a vertically integrated research and development pharmaceutical company, announced that it has received final approval from the US Food & Drug Administration ...

Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...